Fresa, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 348
EU - Europa 291
AS - Asia 27
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 670
Nazione #
US - Stati Uniti d'America 346
IT - Italia 128
SE - Svezia 64
IE - Irlanda 33
DE - Germania 24
CN - Cina 13
FR - Francia 9
IN - India 8
CZ - Repubblica Ceca 6
ES - Italia 6
GB - Regno Unito 5
FI - Finlandia 4
HK - Hong Kong 3
IR - Iran 3
PL - Polonia 3
CI - Costa d'Avorio 2
NL - Olanda 2
UA - Ucraina 2
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BR - Brasile 1
CA - Canada 1
MC - Monaco 1
MX - Messico 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 670
Città #
Chandler 89
Ashburn 46
Florence 36
Dublin 33
Rome 32
New York 26
Milan 23
Bremen 12
Princeton 12
Boston 9
Marseille 8
San Mateo 8
Wilmington 8
Beijing 7
North Hollywood 5
Pavia 5
Washington 5
Brdo 4
Los Angeles 4
Arezzo 3
Central 3
Chicago 3
Fairfield 3
Helsinki 3
Pune 3
San Marzano sul Sarno 3
Seville 3
Abidjan 2
Amsterdam 2
Bangalore 2
Brno 2
Garden City 2
Gdansk 2
Guangzhou 2
London 2
Michigan City 2
Napoli 2
Norwalk 2
Nuremberg 2
Redwood City 2
Turin 2
Vigo 2
Woodbridge 2
Zanjan 2
Albuquerque 1
Augusta 1
Berlin 1
Brussels 1
Busto Arsizio 1
Chiswick 1
Dearborn 1
Frankfurt am Main 1
Haikou 1
Hefei 1
Houston 1
Hyderabad 1
Jacksonville 1
Jiaxing 1
Kashan 1
Lappeenranta 1
Lisbon 1
Monaco 1
Mumbai 1
Munich 1
Nizhniy Novgorod 1
Phoenix 1
Santarcangelo di Romagna 1
Seattle 1
Segni 1
Shanghai 1
Stockholm 1
Vancouver 1
Vienna 1
Vinhedo 1
Warsaw 1
Totale 461
Nome #
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 60
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 55
the concomitance of lymphoma and breast carcinoma in the bone 50
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 45
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 41
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 41
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib? 40
The concomitance of lymphoma and breast carcinoma in the bone 40
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 38
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 37
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 32
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 30
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 26
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 22
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 19
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 18
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study 17
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 16
Richter transformation in Chronic Lymphocytic Leukemia 15
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 13
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL 12
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 10
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study 9
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 8
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 7
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 7
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 2
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 2
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 2
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study 1
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 1
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 1
Role of microRNAs in Chronic Lymphocytic Leukemia 1
Totale 718
Categoria #
all - tutte 4.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 0 0 0 5 1 0 0 0 9 2
2020/20218 0 0 0 0 1 0 2 0 2 0 3 0
2021/202290 0 3 7 2 8 0 1 10 6 0 35 18
2022/2023314 38 37 14 37 25 28 13 23 48 17 31 3
2023/2024289 6 68 22 37 16 57 32 21 2 27 1 0
Totale 718